Cancer therapies and diagnostics, October 2022
This 2-day course gives an overview of the present understanding of tumor biology, with a focus on immune and targeted therapies as well as on precision medicine.
Purpose and goal
The two main goals are to:
- provide an overview of the biological mechanisms that underlie cancer initiation, growth, and metastasis
- discuss how novel cancer treatment strategies and drugs have been - and will be - developed based on an improved understanding of cancer biology.
The course will provide participants with a conceptual framework that will support well-informed evaluation of the novelty and significance of emerging findings in the areas of tumor biology and drug development.
Target group
The course is directed towards pharmaprofessionals with a profound interest in novel diagnostics and treatment approaches.
Basic knowledge of cell/tumor biology is recommended, whether from academic training or professional experience from the oncology subfield of pharmaceutical companies, or both.
Participants with a deep interest, that have attended the Introduction course are also welcome to apply.
Course team
The course will involve active researchers representing leading national expertise in tumor biology and clinical research, providing complementary perspectives on how biological research can be transformed to novel treatments.
Course content
The tumor biology part of the course presents an overview of current understanding of the biological mechanisms underlying tumor initiation, growth and progression and covers concepts such as:
- The tumor microenvironment
- Cancer immune surveillance
- Novel immune therapies¨
- Novel targeted cancer drugs
- Precision medicine
- Early detection and diagnosis
- Clinical trials
Course set-up
The course will consist of lectures and seminars as well as some online course literature accessible on a web portal. The course format will encourage direct and informal interactions between participants and lecturers. The course is provided in a larger context that recognizes the potential of novel collaborative formats between academic and company-driven cancer research.
More information
For about course content, please contact:
Charlotte Rolny ph, course leader,
Department of Oncology-Pathology
Email: charlotte.rolny@ki.se
Hanna Eriksson PhD,MD, co-organizer
Email: Hanna.Eriksson@ki.se
For questions about administrative issues, please contact:
Susanna Sjunneryd, project coordinator
Karolinska Institutet Executive and Professional Education
E-mail: susanna.sjunneryd@ki.se
Course dates and venue
20-21th of October 2022. Campus Solna, Karolinska Institutet, Solna.
Course Schedule
Day 1 - The tumor microenvironment; current and novel therapies
8.30-08.45: Welcome; introduction, Charlotte Rolny, Hanna Eriksson
08.45-09.30: Hallmarks of cancer, Charlotte Rolny
09.30 -10.15: The current and next generation immunotherapies, Andreas Lundqvist and Hanna Eriksson
10.15-10.30: Coffee
10.30-11.15: Tumor antigens and tumor vaccine, Rolf Kiessling
11.15-12.00: Adoptive transfer of NK cells, Hans-Gustav Ljunggren
12.00-13.00: Lunch
13.00-13.45: The role of immunosuppressive and pro-metastatic macrophages in cancer, Charlotte Rolny
13.45-14.30: The role of fibroblasts in cancer: PDGFR expression on stromal cells as prognostic and predictive biomarkers, Arne Östman
14.30-14.45: Coffee
14.15-15.00: TKI and checkpoint inhibiters and beyond in lung cancers, Simon Ekman
15.35-16.15: TBT
16.25-17: Discussions and questions
Day 2 - Precision Medicine and novel therapies
9.00-9.45: Precision Medicine an overview, Päivi Östling
9.45-10.30: Proteomics in precision medicine, Janne Lehtiö
10.30-10.45: Coffee
10.45-11.15: Radiology as a tool in precision medicine, Lennart Blomquist
11.15 12.00: AI in pathology, Johan Hartman
12.00-13.00: Lunch
13.00-13.45: Targeting the DNA damage response DDR, Thomas Heliday
13 .45-14.30: TBT GI
14.30-14.45: Coffee
14.45-15.30: Clinical Trials, Elham Hedayati
15.30-16.30: Beehives
Application
We will strive for an even distribution among the member companies of LIF. Please note that if the number of applicants exceeds the number of places available, an even distribution among the member companies of LIF will be made.
The course is conducted under the condition that we receive a sufficient number of participants.
Brief information about the course
About Executive and Professional Education at KI
Competence development for health care professionals
Competence development for health care professionals
Karolinska Institutet offers competence development for health care professionals in areas such as global & public health, primary care, dentistry and management & organisation. The courses are led by leading experts, based on the latest research and are designed to advance your practice of health care and improve your patient outcomes.